UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005321
Receipt number R000005635
Scientific Title Clinical evaluation of molecular detection for sentinel lymph node examination in breast cancer patients
Date of disclosure of the study information 2011/04/01
Last modified on 2011/03/26 16:03:23

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical evaluation of molecular detection for sentinel lymph node examination in breast cancer patients

Acronym

Sentinel lymph node examination by means of the OSNA method

Scientific Title

Clinical evaluation of molecular detection for sentinel lymph node examination in breast cancer patients

Scientific Title:Acronym

Sentinel lymph node examination by means of the OSNA method

Region

Japan


Condition

Condition

Primary breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Clinical evaluation of the OSNA method in detection of sentinel lymph node metastasis in breast cancer patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Comparison of sensitivity for detection of metastasis between the OSNA assay and conventional pathology

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

Axillary dissection is omitted for patients who have no sentinel node metastasis examined by means of the OSNA assay.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Clinical N0 primary breast cancer patients who undergo sentinel lymph node biopsy

Key exclusion criteria

Patients without their consent.
Patients who underwent primary systemic chemotherapy or primasy systemic hormonal therapy before sentinel lymph node biopsy.

Target sample size

450


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shinzaburo Noguchi

Organization

Osaka University Graduate School of Medicine

Division name

Breast and Endocrine Surgery

Zip code


Address

2-2-E10, Yamadaoka, Suita, Osaka, Japan

TEL

06-6879-3772

Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Osaka University Graduate School of Medicine

Division name

Breast and Endocrine Surgery

Zip code


Address


TEL


Homepage URL


Email



Sponsor or person

Institute

Japanese Study Group of the OSNA assay

Institute

Department

Personal name



Funding Source

Organization

Nakatani foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2009 Year 05 Month 11 Day

Date of IRB


Anticipated trial start date

2009 Year 10 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 03 Month 26 Day

Last modified on

2011 Year 03 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005635


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name